EMEA-001831-PIP01-15

  • Email
  • Help

Overview

Product details for -
Invented name-
Active substance

Monoclonal IgG1 anti-influenza A antibody

Decision numberP/0300/2016
PIP numberEMEA-001831-PIP01-15
Pharmaceutical form(s)Concentrate for solution for infusion
Condition(s)/indication(s)

Treatment of influenza

Route(s) of administrationIntravenous use
PIP applicant

Roche Products Limited
Switzerland
Tel. +41 6168 79411
E-mail: info.paediatrics@roche.com

Decision typeP: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

Related documents